Glendon E. III French, a director at $LUNG, sold 43,036 shares of the company on 02-20-2025 for an estimated $350,313. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.0% of their shares of this class of stock. Following this trade, they now own 1,024,391 shares of this class of $LUNG stock.
$LUNG Insider Trading Activity
$LUNG insiders have traded $LUNG stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- GLENDON E. III FRENCH has made 0 purchases and 7 sales selling 120,000 shares for an estimated $913,511.
- DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 8 sales selling 11,262 shares for an estimated $72,582.
- GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 8 sales selling 8,962 shares for an estimated $57,785.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LUNG Hedge Fund Activity
We have seen 60 institutional investors add shares of $LUNG stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 1,534,763 shares (+inf%) to their portfolio in Q4 2024, for an estimated $10,421,040
- VICTORY CAPITAL MANAGEMENT INC removed 834,301 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $6,916,355
- MORGAN STANLEY removed 716,107 shares (-18.9%) from their portfolio in Q4 2024, for an estimated $4,862,366
- ALTIUM CAPITAL MANAGEMENT LP added 500,000 shares (+inf%) to their portfolio in Q3 2024, for an estimated $4,144,999
- PFM HEALTH SCIENCES, LP removed 368,929 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,505,027
- JPMORGAN CHASE & CO removed 287,092 shares (-27.2%) from their portfolio in Q4 2024, for an estimated $1,949,354
- POINT72 ASSET MANAGEMENT, L.P. removed 240,949 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,997,467
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
